A comparison of single-dose spectinomycin with five days of trimethoprim-sulfamethoxazole for the treatment of chancroid. 1987

L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot

In a controlled trial 32 patients with ulcers culture-positive for Haemophilus ducreyi were treated with a single 2-g dose of spectinomycin, and 20 patients were treated with a five-day course of trimethoprim-sulfamethoxazole (TMP-SMZ; 160/800 mg) twice daily. Both regimens rapidly eradicated H. ducreyi from ulcers, with subsequent healing of ulcers and buboes. The cure rates 14 days after initiation of therapy were 94% for spectinomycin and 95% for TMP-SMZ. Patients with H. ducreyi-negative ulcers who were treated with the same regimens also healed and did not show a significantly different efficacy for either regimen. Thus we found that the one-day regimen of spectinomycin was as effective for the treatment of chancroid as was TMP-SMZ given for five days. Further studies on a larger number of patients are needed to confirm our findings.

UI MeSH Term Description Entries
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002602 Chancroid Acute, localized autoinoculable infectious disease usually acquired through sexual contact. Caused by HAEMOPHILUS DUCREYI, it occurs endemically almost worldwide, especially in tropical and subtropical countries and more commonly in seaports and urban areas than in rural areas.
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000198 Spectinomycin An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of GONORRHEA. Actinospectacin,Adspec,Ferkel Spectam,Kempi,Prospec,Salmosan-T,Spectam,Spectinomycin Dihydrochloride, Anhydrous,Spectinomycin Dihydrochloride, Pentahydrate,Spectinomycin Hydrochloride,Stanilo,Trobicin,Salmosan T,Spectam, Ferkel
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole

Related Publications

L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
January 1992, Sexually transmitted diseases,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
October 1981, JAMA,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
July 1985, The Journal of antimicrobial chemotherapy,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
April 1995, Genitourinary medicine,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
July 1983, The New England journal of medicine,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
January 1986, Sexually transmitted diseases,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
March 1978, Canadian Medical Association journal,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
August 1978, Canadian Medical Association journal,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
August 1978, Canadian Medical Association journal,
L Fransen, and H Nsanze, and Jo-Ndinya-Achola, and L D'Costa, and A R Ronald, and P Piot
January 1982, Reviews of infectious diseases,
Copied contents to your clipboard!